Midwest Peptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are sold for research use only (RUO), are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.

A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management. Premium Research Peptide.
Add $80.01 more to save 8% off
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
A long-acting amylin analog being evaluated in research environments.
For Laboratory Research Only: Cagrilintide is sold exclusively for scientific and investigational research. It is not approved for human or animal use, therapeutic protocols, or diagnostic procedures. This product is not classified as a drug or supplement.
⚠️ Disclaimer: Statements provided are for informational purposes only and have not been evaluated by the FDA or any regulatory authority. No claims of effect, efficacy, or use outside of lawful research context are implied.
Terms of Sale: By purchasing from Midwest Peptide, you acknowledge that you are a qualified researcher or institution. You assume full responsibility for compliance with all applicable federal, state, and local laws. All sales are final. Improper use or handling voids all responsibility on our part.
Cagrilintide is a synthetic long-acting amylin analog studied as a research compound for amylin and calcitonin receptor pharmacology. It is structurally related to native human amylin with modifications that extend circulating half-life in research models. Supplied strictly for Research Use Only.
Both are amylin analogs but cagrilintide has a longer circulating half-life in research models. Pramlintide is a shorter-acting analog. Cagrilintide is also studied in research literature in combination with GLP-1 receptor agonists, while pramlintide is typically studied alone.
Cagrilintide is studied in preclinical research on amylin and calcitonin receptor signaling, food intake regulation, body composition partitioning, and combination research with incretin pathway molecules. All cited studies are conducted in rodent or in-vitro systems.
Other research peptides in this category
Research articles and insights related to Cagrilintide

Cagrilintide glucagon crosstalk research covering amylin glucagon interaction, islet paracrine signaling, alpha cell biology, and hepatic glucose output effects. For research use only.
April 24, 2026

Cagrilintide cardiovascular research covering metabolic cardiovascular risk factors, blood pressure effects, and cardiac function in long acting amylin analog research. For research use only.
April 24, 2026

Cagrilintide sourcing guide covering supplier evaluation for a lipidated long acting amylin analog and the Midwest Peptide research catalog. For research use only.
April 14, 2026

Cagrilintide long term weight maintenance research covering chronic body composition, metabolic stability, combined cagrisema dosing, and rodent obesity model outcomes. For research use only.
April 14, 2026
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Every batch of cagrilintide ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry, and lyophilized mass. The batch-specific COA is published on this product page before purchase.
Lyophilized cagrilintide is stored at -20C for long-term storage and 2-8C for short-term use within 30 days. Avoid repeated freeze-thaw cycles. Store in original sealed vials, protected from light.
Cagrilintide is not FDA-approved as a standalone therapeutic. The product supplied here is for laboratory and research use only and is not approved for diagnostic, therapeutic, or human use.